spot_img
Wednesday, April 1, 2026

NJIT and Made Scientific partner to bridge the talent gap in cell and gene therapy

In a move to solidify New Jersey’s standing as the “Medicine Chest of the World,” the New Jersey Institute of Technology (NJIT) and Princeton-based Made Scientific, Inc. announced a strategic partnership to revolutionize graduate-level biotechnology education.

The collaboration will integrate industry-standard bioprocessing curriculum into NJIT’s Master of Science program in Chemical and Materials Engineering. Starting in the Spring 2027 semester, graduate students will have access to elective courses co-developed by Made Scientific’s experts, specifically designed to meet the high stakes demands of Cell and Gene Therapy (CGT) manufacturing.

The partnership leverages the Made Scientific Foundry™ scholar program, a specialized workforce development initiative. Unlike traditional academic courses, this curriculum uses the same workflows, tools, and rigorous standards found in active clinical- and commercial-stage contract development and manufacturing organizations (CDMOs).

“By combining Made Scientific’s hands-on manufacturing expertise… with NJIT’s academic excellence, we are creating a truly differentiated learning experience,” Syed Husain, chairman & CEO of Made Scientific said. “One that will produce industry-ready professionals capable of driving innovation.”

The announcement highlights a full-circle moment for the two organizations; Made Scientific originally grew out of the New Jersey Innovation Institute (NJII), an NJIT entity. This evolution from a university-born startup to a leading CDMO underscores the economic impact of Newark’s burgeoning tech ecosystem.

NJIT President Teik Lim emphasized the broader social and economic goals of the partnership: “Talent is everywhere, but opportunity must be created. This partnership is a great opportunity to equip NJIT graduate students with the hands-on knowledge… to enter the workforce ready to contribute from day one.”

As the biotech industry shifts toward personalized medicine—such as autologous (patient-specific) and allogeneic (off-the-shelf) cell therapies—the complexity of manufacturing has skyrocketed.

  • NJIT’s Role: NJIT is ranked No. 1 in New Jersey among public universities for alumni salaries by the Wall Street Journal.
  • Made Scientific’s Role: Headquartered in Princeton, the firm specializes in the development and release of complex cell therapy products.

Moshe Kam, Dean of NJIT’s Newark College of Engineering, noted that the immersive nature of the program will “strengthen New Jersey’s position as a global leader in biomanufacturing.”

Get the Latest News

Sign up to get all the latest news, offers and special announcements.

Get our Print Edition

All the latest updates, delivered.

Latest Posts

Get the Latest News

Sign up to get all the latest news, offers and special announcements.

Get our Print Edition

All the latest updates, delivered.